These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15952919)

  • 1. Pharmacotherapy, vaccines and malaria advice for HIV-infected travellers.
    Cavassini ML; D'Acremont V; Furrer H; Genton B; Tarr PE
    Expert Opin Pharmacother; 2005 Jun; 6(6):891-913. PubMed ID: 15952919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV and travel].
    D'Acremont V; Cavassini ML; Tarr PE; Genton B
    Rev Med Suisse; 2005 May; 1(19):1268-74. PubMed ID: 15962624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advice to HIV infected persons travelling to tropical or subtropical destinations].
    Oehler T; Büchel B; Hatz C; Furrer H
    Schweiz Med Wochenschr; 2000 Jul; 130(27-28):1041-50. PubMed ID: 10953854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Travel medicine for HIV-infected patients].
    Rossi M; Furrer H
    Ther Umsch; 2001 Jun; 58(6):381-6. PubMed ID: 11441700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Travel patterns and risk behaviour of HIV-positive people travelling internationally.
    Salit IE; Sano M; Boggild AK; Kain KC
    CMAJ; 2005 Mar; 172(7):884-8. PubMed ID: 15795409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIV-positive traveler.
    Bhadelia N; Klotman M; Caplivski D
    Am J Med; 2007 Jul; 120(7):574-80. PubMed ID: 17602926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and travel.
    Schuhwerk MA; Richens J; Zuckerman JN
    Travel Med Infect Dis; 2006; 4(3-4):174-83. PubMed ID: 16887739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Travelling with HIV in the XXI century: Case report and narrative review.
    Perez-Molina JA; Crespillo-Andújar C; Moreno S; Serrano-Villar S; López-Vélez R
    Travel Med Infect Dis; 2020; 38():101921. PubMed ID: 33220457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.
    Mermin J; Ekwaru JP; Liechty CA; Were W; Downing R; Ransom R; Weidle P; Lule J; Coutinho A; Solberg P
    Lancet; 2006 Apr; 367(9518):1256-61. PubMed ID: 16631881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinations and malaria prophylaxis for long-term travellers travelling from Greece: a prospective, questionnaire-based analysis.
    Pavli A; Smeti P; Spilioti A; Silvestros C; Katerelos P; Maltezou HC
    Travel Med Infect Dis; 2014; 12(6 Pt B):764-70. PubMed ID: 24957561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Travel medicine and HIV infection.
    Igreja R
    Int J STD AIDS; 2008 Sep; 19(9):577-80. PubMed ID: 18725545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enquiries to the United Kingdom National Travel Advice Line by healthcare professionals regarding immunocompromised travellers.
    Allen JE; Patel D
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 27021497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study.
    Eholié SP; Ello FN; Coffie PA; Héma A; Minta DK; Sawadogo A
    Trop Med Int Health; 2017 Sep; 22(9):1186-1195. PubMed ID: 28653454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for malaria prevention in moderate to low risk areas: travellers' choice and risk perception.
    Voumard R; Berthod D; Rambaud-Althaus C; D'Acremont V; Genton B
    Malar J; 2015 Apr; 14():139. PubMed ID: 25889529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Travel vaccination recommendations and infection risk in HIV-positive travellers.
    Chang L; Lim BCW; Flaherty GT; Torresi J
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 31066446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human immunodeficiency virus-infected traveler.
    Castelli F; Patroni A
    Clin Infect Dis; 2000 Dec; 31(6):1403-8. PubMed ID: 11096010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.